IRR's Unattributed - II Round

IRR raised a round of funding on November 24, 2017.

Inflammatory Response Research (IRR) is a drug development company focused on pharmaceutical products for the treatment of inflammatory disorders and conditions. The company's initial product is a com…

Articles about IRR's Unattributed - II Round: